Helius Medical Technologies, Inc. Class A HSDT 深 滬
等待開盤 09-02 09:30:00 美东时间
6.12
-0.095
-1.53%
華盛通- 最 高6.19
- 今 開6.13
- 成交量 1.20万股
- 最 低 6.0364
- 昨 收 6.215
- 總市值 2188.63万
- 52周最高 1200.00
- 市盈率 靜 --
- 換手率 0.34%
- 52周最低 5.37
- 委 比 6.10%
- 總股本 357.62万
- 歷史最高 17325000.00
- 量 比 0.52
- 振 幅 2.47%
- 歷史最低 6.0364
- 每 手 1
- 風險率 2.87%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Helius Medical Tech Q2 EPS $(79.73) Beats $(128.50) Estimate, Sales $43.000K Miss $75.000K Estimate
Helius Medical Tech (NASDAQ:HSDT) reported quarterly losses of $(79.73) per share which beat the analyst consensus estimate of $(128.50) by 37.95 percent. This is a 83.39 percent increase over losses of $(480.00) per
08-15 05:50
Helius Medical Technologies (HSDT) Stock Is Surging Today: What's Happening?
Helius Medical Technologies Inc (NASDAQ:HSDT) shares are rising Monday after the company announced a positive outcome from the Portable Neuromodulation Stimulator (PoNS) Stroke Registrational Program.
07-21 21:25
Market-Moving News for July 21st
XYZ: 10% | Block Will Replace Hess Corp. In The S&P 500 Effective Prior To The Opening Of Trading On Wednesday, July 23 GCTK: 105% | Glucotrack Repurchases Over 90% Of Series A Warrants From $10M
07-21 19:22
Helius Announces Positive Outcome of the Portable Neuromodulation Stimulator PoNS® Stroke Registrational Program and Upcoming Submission to FDA Under Breakthrough Designation
Helius Medical Technologies announced positive outcomes from the PoNS Stroke Registrational Program (SRP), supporting an FDA submission for gait and balance deficits in stroke patients. The program included three clinical trials with 159 participants, demonstrating statistically significant improvements in gait and balance, minimal adverse events, and good tolerability. Helius plans to submit for FDA approval under Breakthrough Device Designation...
07-21 11:00
Hyperscale Data Declares Monthly Cash Dividend of $0.2708333 per Share of 13.00% Series D Cumulative Redeemable Perpetual Preferred Stock
Hyperscale Data Inc. announced that its Board of Directors has declared monthly cash dividends of $0.2708333 per share for its 13.00% Series D Cumulative Redeemable Perpetual Preferred Stock and $0.20833 per share for its 10.00% Series E Cumulative Redeemable Perpetual Preferred Stock. Both dividends have a record date of July 31, 2025, and a payment date of August 11, 2025. Hyperscale Data is a diversified holding company currently operating dat...
07-16 10:59
Hyperscale Data Reduces Debt by Over $20 Million, Strengthens Balance Sheet Ahead of Planned Michigan AI Data Center Expansion
Hyperscale Data, Inc. has reduced its outstanding debt by over $20 million, a major milestone in its transformation into a pure-play AI data center platform. The company plans to expand its 617,000-square-foot data center in Michigan, aiming to become a leading AI hub in North America. Upgrades include increasing power capacity to 340 MW, supporting AI and high-performance computing. Hyperscale Data expects to complete its separation from Ault Ca...
07-14 10:59
Helius Medical Regains Nasdaq Compliance
Helius Medical Technologies ( ($HSDT) ) has shared an update. On July 7, 2025, ...
07-09 21:32
Why ENDRA Life Sciences Shares Are Trading Higher By Over 61%; Here Are 20 Stocks Moving Premarket
Shares of ENDRA Life Sciences Inc. (NASDAQ:NDRA) rose sharply in pre-market tra...
07-08 18:15
Helius Medical Technologies shares are trading lower after the company announced a 1-for-50 reverse stock split.
Helius Medical Technologies shares are trading lower after the company announce...
06-27 21:33
